Latest News about MRK
Recent news which mentions MRK
Why Genprex Shares Are Soaring Today
January 03, 2022
From Benzinga
Genprex's Lead Cancer Program Scores Second FDA Fast Track Tag For Lung Cancer Setting
January 03, 2022
From Benzinga
These 3 Stocks Just Hiked Their Dividends: Should You Buy Them?
January 01, 2022
From Motley Fool
Daily average of COVID hospitalizations rises above 80,000 for the first time in 3 months, while cases keep breaking daily records
December 31, 2021
From MarketWatch
Wall Street analysts’ favorite stocks for 2022 include Alaska Air, Caesars and Lithia Motors
December 31, 2021
From MarketWatch
From MarketWatch
These 8 Dow Jones Stocks Are Negative For 2021
December 30, 2021
From Benzinga
These are the best-performing S&P 500 and Nasdaq-100 stocks of 2021
December 30, 2021
From MarketWatch
Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant
December 29, 2021
From Benzinga
The U.S. is rolling out Pfizer and Merck’s COVID-19 antivirals to states but ‘complex’ manufacturing process may limit launch
December 28, 2021
From MarketWatch
Top Investing Headlines of 2021
December 27, 2021
From Motley Fool
Some "CEO of the Year" Nominees for 2021
December 27, 2021
From Motley Fool
Holiday Shopping Saw Growth in Apparel and Jewelry
December 27, 2021
From Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
December 26, 2021
From Benzinga
Benzinga's Bulls And Bears Of The Past Week: Alibaba, Disney, NVDIA, Coinbase, Hubspot, JD.com And More
December 25, 2021
From Benzinga
How Much Revenue Could Pfizer's Oral COVID-19 Pill Fetch?
December 23, 2021
From Benzinga
Why Moderna Stock Is Falling Again Today
December 23, 2021
From Motley Fool
FDA Approves Another COVID-19 Antiviral Pill, This Time From Merck
December 23, 2021
From Benzinga
Investors Appear Uninterested in Bonds Despite Elevated Uncertainty
December 22, 2021
From Benzinga
From Benzinga
FDA To Possibly Authorize Pfizer, Merck COVID-19 Antiviral Pills This Week: Bloomberg
December 22, 2021
From Benzinga
UK Calls For Additional Doses Of COVID-19 Antivirals From Merck, Pfizer
December 22, 2021
From Benzinga
The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda
December 22, 2021
From Benzinga
Why growth and dividend stocks will be hot items for 2022, along with these super-productive companies
December 22, 2021
From MarketWatch
Buy Palantir Stock While the Analysts Remain Bearish
December 22, 2021
From InvestorPlace
From Benzinga
Bristol Myers Squibb Stock: Bull vs. Bear
December 21, 2021
From Motley Fool
Will Eli Lilly Be a Top Pharma Stock Again in 2022?
December 19, 2021
From Motley Fool
EMA's CHMP Backs Approval For Merck's Keytruda In Adjuvant Setting For Kidney Cancer
December 17, 2021
Tickers
MRK
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.